Holen Sie sich die Stockscreener-App
2.24
4.27%
-0.10
Handel nachbörslich:
2.20
-0.04
-1.79%
Schlusskurs vom Vortag:
$2.34
Offen:
$2.34
24-Stunden-Volumen:
11.55M
Relative Volume:
1.48
Marktkapitalisierung:
$672.83M
Einnahmen:
$188.87M
Nettoeinkommen (Verlust:
$-400.38M
KGV:
-1.4933
EPS:
-1.5
Netto-Cashflow:
$-260.90M
1W Leistung:
+7.18%
1M Leistung:
+50.34%
6M Leistung:
+98.23%
1J Leistung:
-8.20%
1-Tages-Spanne:
$2.16
$2.34
1-Wochen-Bereich:
$1.91
$2.37
52-Wochen-Spanne:
$0.8511
$2.72
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
Firmenname
Pacific Biosciences Of California Inc
Sektor
Branche
Telefon
650-521-8000
Adresse
1305 O'BRIEN DRIVE, MENLO PARK, CA
Vergleichen Sie PACB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.24 | 702.87M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-11 | Herabstufung | UBS | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-04-18 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-17 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-31 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-06-30 | Eingeleitet | Goldman | Buy |
| 2023-05-10 | Eingeleitet | Barclays | Equal Weight |
| 2023-03-31 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2023-01-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-03-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-15 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | Eingeleitet | Cowen | Outperform |
| 2017-11-03 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | Herabstufung | CL King | Buy → Neutral |
| 2016-11-03 | Bestätigt | Cantor Fitzgerald | Buy |
| 2016-06-27 | Eingeleitet | CL King | Buy |
| 2016-04-15 | Eingeleitet | First Analysis Sec | Overweight |
| 2016-02-04 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | Bestätigt | Cantor Fitzgerald | Buy |
| 2015-10-23 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-02-04 | Bestätigt | Maxim Group | Buy |
| 2013-09-26 | Bestätigt | Maxim Group | Buy |
| 2013-01-14 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
Pacific Biosciences of California Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Pacific Biosciences of California showcases live Vega demos at AMP 2025 - Traders Union
How to build a custom watchlist for Pacific Biosciences of California Inc.July 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
Will Pacific Biosciences of California Inc. stock recover after recent dropTake Profit & Real-Time Chart Breakout Alerts - newser.com
Is Pacific Biosciences of California Inc. stock a top pick in earnings seasonTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Analyzing recovery setups for Pacific Biosciences of California Inc. investors2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
Smart tools for monitoring Pacific Biosciences of California Inc.’s price action2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Price action breakdown for Pacific Biosciences of California Inc.July 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com
Statistical indicators supporting Pacific Biosciences of California Inc.’s strengthProduct Launch & Verified High Yield Trade Plans - newser.com
Is Pacific Biosciences of California Inc. (P09) stock resilient in recession scenariosWatch List & Trade Opportunity Analysis - newser.com
Can Pacific Biosciences of California Inc. stock resist market sell offsWeekly Market Report & Safe Capital Growth Tips - newser.com
Does Pacific Biosciences of California Inc. stock trade at a discount to peersJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com
Why Pacific Biosciences of California Inc. stock is favored by top institutionsJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Will Pacific Biosciences of California Inc. continue its uptrend2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com
Is Pacific Biosciences of California Inc. (P09) stock a buy before new product rolloutJobs Report & AI Driven Stock Reports - newser.com
Will Pacific Biosciences of California Inc. stock split attract more investorsTrade Risk Assessment & Weekly High Momentum Picks - newser.com
Custom strategy builders for tracking Pacific Biosciences of California Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
What makes Pacific Biosciences of California Inc. stock attractive to growth fundsEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
Will Pacific Biosciences of California Inc. stock sustain high P E ratios2025 Growth vs Value & Scalable Portfolio Growth Methods - newser.com
Is Pacific Biosciences of California Inc. stock ready for a breakoutEarnings Risk Report & Long-Term Investment Growth Plans - newser.com
What analysts say about Pacific Biosciences of California Inc P09 stockAutomated Trading Signals & Small Capital Wealth Plans - earlytimes.in
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap UpHere's What Happened - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Shareholders Are up 16% This Past Week, but Still in the Red Over the Last Five Years - 富途牛牛
Carret Asset Management LLC Buys New Holdings in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences of California, Inc. (PACB) latest stock news and headlines - Yahoo! Finance UK
ARK’s PACB Share Buy: Could Institutional Confidence Signal a Turning Point for Pacific Biosciences? - Yahoo Finance
Pacific Biosciences of California emphasizes advanced research initiatives - Traders Union
PacBio (PACB) Shares Skyrocket, What You Need To Know - Yahoo Finance
Can Pacific Biosciences of California Inc. stock deliver strong Q4 earningsMarket Performance Recap & Community Consensus Stock Picks - newser.com
How resilient is Pacific Biosciences of California Inc. stock in market downturns2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - newser.com
Ranking Pacific Biosciences of California Inc. among high performing stocks via toolsEntry Point & Stock Market Timing Techniques - newser.com
Is Pacific Biosciences of California Inc. (P09) stock at risk of policy regulationQuarterly Portfolio Summary & Smart Allocation Stock Tips - newser.com
Finanzdaten der Pacific Biosciences Of California Inc-Aktie (PACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):